Provider Alerts

Horizon Medicare Advantage NJ DIRECT (PPO)

Effective January 1, 2019, Horizon Blue Cross Blue Shield of New Jersey will no longer administer Medicare Advantage (MA) PPO plans for the New Jersey State Health Benefits Program (SHBP).

FDA issues lamotrigine (Lamictal®) warning

On April 25, 2018, the U.S. Food and Drug Administration (FDA) issued a warning that the medicine lamotrigine (Lamictal) can cause a rare but very serious reaction known as hemophagocytic lymphohistiocytosis (HLH).

Provider Alert: Zinbryta

On March 2, 2018, Biogen and AbbVie announced the voluntary worldwide withdrawal of Zinbryta® (daclizumab), a medicine used to treat relapsing multiple sclerosis.

Remember to check your claims error reports before calling about claim status

If an electronic claim is rejected, you will receive an error report, either the 999 or the 277CA Claims Acknowledgement Report that explains why the claim was rejected.

Duplicate EOPs statements on NaviNet

Horizon BCBSNJ is aware of an EFT issue that is resulting in the display of duplicate Explanation of Payment (EOP) statements within NaviNet’s Payment Status inquiry transaction for payments November 3, 2016 and after.

Check eligibility and more

Remember to sign in to NaviNet to check patient eligibility, status of a claim and more.